M Performance Standards for Antimicrobial. Susceptibility Testing. This document includes updated tables for the Clinical and. Laboratory Standards. The tables in CLSI document M,1 when used in conjunction with this standard, represent the most current information for drug selection. [DOWNLOAD] Clsi Guidelines M S23 PDF [BOOK]. Book file PDF easily for everyone and every device. You can download and read online.

Author: Vudojinn Mizshura
Country: Senegal
Language: English (Spanish)
Genre: Technology
Published (Last): 2 December 2006
Pages: 344
PDF File Size: 15.84 Mb
ePub File Size: 8.71 Mb
ISBN: 928-7-67174-566-8
Downloads: 63517
Price: Free* [*Free Regsitration Required]
Uploader: Grogore

Flsi results also were observed for oritavancin, indicating that the presence of P at 0. Initial quality control evaluations for susceptibility testing of dalbavancin BIan investigational glycopeptide with potent Gram-positive activity. Food and Drug Administration. The aim of the study described in this paper was to comparatively evaluate the traditional susceptibility testing for MRSA with PCR as the gold standard assay.

The results presented here also validate a commercial dry-form formulation panel, which can be used as an alternative method for telavancin susceptibility testing in the clinical microbiology setting, along with adequate QC cllsi and interpretive breakpoints 389. Laboratory identification of MRSA is crucial and essential both for initiation of appropriate antimicrobial therapies and for effective infection control strategies that are designed to limit the spread of MRSA.

Lastly, the telavancin in vitro MIC results tested against Gram-positive organisms by the revised BMD method are now comparable to those reported for other lipoglycopeptide agents i.

Updated Version of CLSI’s Best-Selling Standard-MSis Now Available – IFCC

In contrast, the disk diffusion methods with oxacillin and cefoxitin showed lower sensitivity clai In spite of the availability of commercial kits for MRSA detection in the market, the Clinical and Laboratory Standards Institute CLSI recommends the use of phenotypic methods, such as the disk diffusion method with oxacillin or with cefoxitin, as well as a serial dilution method with oxacillin. Open in a separate window.


All telavancin MIC QC values obtained by frozen-form panels prepared according to the previous and revised methods were within the ranges published in the Clxi and MS24 documents, respectively 38— This is secondary to the use of DMSO for panel production and clsj presence of P, which ensure the proper telavancin testing concentration and result in a more accurate MIC determination.

Support Center Support Center. Similar experiments were performed for telavancin, and similar results were obtained data on file; Theravance, Inc. Advancing excellence in laboratory medicine for better healthcare worldwide.

For additional information, visit the CLSI website at www. South San Francisco, CA. Telavancin activity tested against a contemporary collection of Gram-positive pathogens vlsi USA hospitals Comparative surveillance study of telavancin activity against recently collected Gram-positive clinical isolates from across the United States.

During the development of this revised method, previous telavancin MIC determinations obtained when E23 was added only at the latest step bacterial inoculation resulted in MIC values against S. TABLE 1 MIC result variations and summary of essential agreement rates between previously established broth microdilution method and revised reference method for telavancin.

National Center for Biotechnology InformationU. Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.

These antimicrobial profile characteristics have been very well documented in studies performed during drug development or after regulatory approval when applying the previous BMD method 1213— Work more efficiently by providing the latest recommendations s233 detecting emerging resistance in c,si easy-to-use format.

Abstract The reference broth microdilution BMD antimicrobial susceptibility testing method for telavancin was revised to include dimethyl sulfoxide S233 as a solvent and diluent for frozen-form panel preparation, following the CLSI recommendations for water-insoluble agents. The revised method and subsequent differences in MIC results prompted the reestablishment of QC ranges for telavancin 9 and interpretive breakpoints 3. Four hundred sixty-two Gram-positive isolates, including a challenge set of organisms with reduced susceptibilities to comparator agents, were selected and tested using the revised method for telavancin, and the MIC results were compared with those tested by cldi previously established method and several Sensititre dry-form BMD panel formulations.


The antimicrobial susceptibility testing for these lipoglycopeptide agents was revised 67and updated quality control QC ranges for dalbavancin and oritavancin were established and published by the Clinical and Laboratory Standards Institute CLSIin MS24 and previous documents 8. Further investigations proposed the use of m10 sulfoxide DMSO as the solvent for stock solution preparation, as well as a stock solution diluent for panel preparation.

Communications and Publications

FarrellRodrigo E. Telavancin is a lipoglycopeptide antibiotic with potent in vitro bactericidal activity when tested against Gram-positive bacteria, including methicillin-susceptible Staphylococcus aureus MSSAmethicillin-resistant S. Methicillin-resistant Staphylococcus aureus MRSA is a multi-drug resistant pathogen, which is responsible for increasing cases of serious diseases, including life-threatening diseases and nosocomial and community-acquired infections.

Telavancin MIC values obtained by the d23 method were considered reference results for these analyses. Journal List Antimicrob Agents Chemother v.

Oritavancin activity against Staphylococcus aureus causing invasive infections in USA and European hospitals. There is a version specifically designed for pharmacists to enhance the implementation of M information tailored to their organization.

TABLE 3 MIC result variations and summary of essential agreement rates between dry-form broth microdilution formulation panel Sensititre and revised reference method for telavancin. Several Sensititre dry-form broth microdilution panel candidate formulations eight were manufactured and tested simultaneously with the previous and revised frozen-form panels.

MendesPaul R.